1. CP-029 How to deal with a new drug interaction? example of the contraindication alfuzosin–strong CYP3A4 inhibitors. (14th February 2016) Authors: Bensalah, N; Carpentier, I; Locher, F; Garcia, S Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DD-021 Medicine supply chain of a central pharmacy: Risk mapping of shortage. (14th February 2016) Authors: Charra, F; Dubromel, A; Bourge, X; Meunier, A; Locher, F; Derain, L Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DD-026 New market for medicines: Do the suppliers meet their commitments?. (14th February 2016) Authors: Kamel, A Bel; Derain, L; Bellossi, F; Locher, F; Meunier, A Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DI-052 Stability study of ceftazidime mylan through use in the ambulatory treatment of cystic fibrosis. (14th February 2016) Authors: Bourge, X; Pages, J; Carpentier, I; Locher, F; Terrier, A Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PS-046 Materiovigilance ex ante risk management. (14th February 2016) Authors: Dubromel, A; Charra, F; Bourge, X; Philibert, M; Locher, F; Derain, L Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗